Two companies – Pfizer and Moderna – have  applied for emergency use authorization from the U.S. Food and Drug Administration for their two-shot vaccine candidates, and more companies are expected to apply in the coming months. 

Our goal is to provide on-site COVID-19 shot clinics for companies, but we are waiting to learn more about how vaccine will be distributed across the country. With our 20+ years of experience with corporate flu shot clinics, we have a solid infrastructure that can be utilized for COVID-19 vaccination programs.

Here is what we know based on information from the CDC:

Limited COVID-19 vaccine is available now, but COVID-19 vaccine supply will increase substantially in the spring.

• Initially available COVID-19 vaccines will either be approved as licensed vaccines or authorized for use under an Emergency Use Authorization (EUA) issued by the U.S Food and Drug Administration (FDA).
• Cold chain storage and handling requirements for each COVID-19 vaccine product will vary from refrigerated (2° to 8°C) to frozen (-20°C) to ultra-cold (-60° to -80°C) temperatures. This could impact delivery to sites. 
• For most vaccines, two doses of COVID-19 vaccine, separated by either 21 or 28 days, will be needed for immunity, and second-dose reminders for patients will be necessary. Both doses will need to match each other (i.e.,be the same vaccine product).